96381 ⎘
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals; Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
CHEMICAL METHODS FOR MAKING RHAMNOLIPID HYDROLYSATE
#2MIXTURE OF STEREOISOMERS OF A SULFATED GLYCOLIPID
#3MALTOSIDE-, LACTOBIONAMIDE-, MONOGLUCOSIDE-, BRANCHED DIGLUCOSIDE-, SULFOBETAINE-, SULFATE- OR AMINOOXIDE-BASED PERFLUORINATED DETERGENTS AND THEIR USE IN MEMBRANE-PROTEINS APPLICATIONS
#4ALGAL BOTANICAL EXTRACTS RICH IN EICOSAPENTAENOIC ACID AS TRI/DIGLYCERIDE CONJUGATE
#5NEW RHAMNOLIPID OLIGO-ESTERS
#6Compositions for Replacing Chemical Surfactants
#7Modified hexa-acylated neisserial LPS
#8Use of rhamnolipids and/or sophorolipids in coating compositions for obtaining a homogeneous colour appearance of the dry coating film and/or for increasing occupational safety in the production of coating compositions
#9METHODS FOR PRODUCING STEREOISOMERICALLY ENRICHED CARBOHYDRATE-BASED SURFACTANTS
#10CARBOHYDRATE-BASED SURFACTANTS
#11Modified tetra-acylated neisserial LPS
#12Molecules from seaweeds with anti-cancer activity
#13Glycolipids and pharmaceutical compositions thereof for use in therapy
#14Hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, method for radiolabeling hexa-lactoside positron emission tomography (PET) imaging agent for liver receptor with Ga-68, and hexa-lactoside PET imaging agent for liver receptor
#15Rhamnolipid esters as nonionic surfactants for cosmetic use
#16Sphingamide compounds and methods for binding iNKT cells
#17Chemical synthesis method of serotype O51 O-antigen oligosaccharide
#18Method for producing an isolated monoclonal antibody specifically binding to a glycolipid antigen of
#19Formulation systems for antimicrobial glycolipids
#20Rhamnolipid amides for hair scent retention
#21Modified hexa-acylated neisserial LPS
#22Vaccines against serotype 5
#23Method of separating rhamnolipids from a fermentation broth
#24Enhancement of cell cryopreservation with glycolipids
#25Eicosapentaenoic acid (EPA) formulations
#26Glycolipids and pharmaceutical compositions thereof for use in therapy
#27Adjuvants
#28Methods of producing glycolipids
#29Carbohydrate-based surfactants
#30Sophorolipid compound and composition comprising same
#31Methods for preparation of glycosphingolipids and uses thereof
#32Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity
#33Immunity inducer for saccharide antigens
#34Method of preparation of alpha galactosyl ceramides compounds
#35Hydroxylated KRN7000 analogue and use thereof
#36Organic compounds as proantigens for natural killer T cells
#37Carbamate glycolipid and use thereof
#38FOAM ADSORPTION
#39Glycosphingolipids for use in modulating immune responses
#40Mannosylated compounds useful for the prevention and the treatment of infectious diseases
#41One-pot synthesis of alpha/beta--glycolipids
#42Synthesis of carbohydrate-based surfactants
#436″-amino-6″-deoxygalactosylceramides
#44GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAE
#45β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
#46Methods for producing amino-substituted glycolipid compounds
#47Modified-galactosyl ceramides for staining and stimulating natural killer T cells
#48Methods for preparation of glycosphingolipids and uses thereof
#49ACTIVATOR INCLUDING BIOSURFACTANT AS ACTIVE INGREDIENT, MANNOSYL ERYTHRITOL LIPID, AND PRODUCTION METHOD THEREOF
#50Method of stimulating NKT with 6″-amino-6″-deoxygalactosylceramides
#51RHAMNOLIPID BIOSURFACTANT FROM PSEUDOMONAS AERUGINOSA STRAIN NY3 AND METHODS OF USE
#52One-pot synthesis of alpha/beta--glycolipids
#53Esterified α-galactosylceramide
#54α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
#55Increase of immune response and targeting by antigens and/or drug linkage
#56Compositions for and methods of enhancing the immune response to antigens
#57Synthetic archaeal glycolipid adjuvants
#58Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same
#59C—glycolipids with enhanced Th-1 profile
#60Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof
#61COMPOUND HAVING TUMOR-RESIDENT PROPERTY
#62ACTIVATOR INCLUDING BIOSURFACTANT AS ACTIVE INGREDIENT, MANNOSYL ERYTHRITOL LIPID, AND PRODUCTION METHOD THEREOF
#636″-amino-6″-deoxygalactosylceramides
#64Glyceroglycolipid antigen of
#65GLYCOLIPIDS AND ANALOGUES THEREOF AS ANTIGENS FOR NK T CELLS
#66CARBOHYDRATE BASED TOLL-LIKE RECEPTOR (TLR) ANTAGONISTS
#67Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same
#68Compositions for and methods of enhancing the immune response to antigens
#69Modified α-galactosyl ceramides for staining and stimulating natural killer T cells
#70Alpha-galactosyl ceramide analogs and their use as immunotherapies
#71Glycolipids
#72Ceramide derivatives as modulators of immunity and autoimmunity
#73Charged sophorolipids and sophorolipid containing compounds
#746″-amino-6″-deoxygalactosylceramides
#75Method for treating cancer
#76Glycolipids and analogues thereof as antigens for NK T cells
#77Ceramide derivatives as modulators of immunity and autoimmunity
#78Alkoxylated sucrose esters composition
#79Process for preparing alkylglycosides
#80Novel antiretroviral sulfolipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
#81Fermentative production of sophorolipids from soybean and other vegetable oils